(Q86824138)
Statements
Early tumor shrinkage and depth of response predict long-term outcome in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab: results from phase III TRIBE trial by the Gruppo Oncologico del Nord Ovest (English)
C Antoniotti
G Masi
E Cortesi
G Tomasello
R Spadi
A Zaniboni
C Barone
S Vitello
R Longarini
M D'Amico
C Granetto